These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19937791)

  • 21. Closure of extracardiac Fontan fenestration by using the covered Cheatham Platinum stent.
    Marini D; Boudjemline Y; Agnoletti G
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1002-6. PubMed ID: 17492790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter repair of Fontan baffle stenosis and fenestration in two patients using Cook Zenith aortic endografts.
    Madan N; Ellozy S; Love B
    J Invasive Cardiol; 2012 Feb; 24(2):E32-4. PubMed ID: 22294545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First experience with the BioSTAR-device for various applications in pediatric patients with congenital heart disease.
    Hoehn R; Hesse C; Ince H; Peuster M
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):72-7. PubMed ID: 19787660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombosis, fracture, and percutaneous removal of a patent foramen ovale closure device 1 month after successful deployment.
    Gori T; Schräder R; Genth-Zotz S
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):778-81. PubMed ID: 20091815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year clinical and echocardiographic evaluation of the Das AngelWings atrial septal occluder.
    Kay JD; O'Laughlin MP; Ito K; Wang A; Bashore TM; Harrison JK
    Am Heart J; 2004 Feb; 147(2):361-8. PubMed ID: 14760337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional rotational angiography during percutaneous device closure of fontan fenestration.
    Hill J; Bellotti C; Golden A
    World J Pediatr Congenit Heart Surg; 2013 Jul; 4(3):324-5. PubMed ID: 24327509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. This much we do know: Sano conduit closure with the Amplatzer vascular plug.
    Lucas V
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):710. PubMed ID: 20976752
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of covered stents to occlude extracardiac Fontan fenestration].
    Boudjemline Y; Agnoletti G; Marini D; Bonnet D; Sidi D
    Arch Mal Coeur Vaiss; 2006 May; 99(5):424-8. PubMed ID: 16802729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful transcatheter closure of a Fontan fenestration with a bioabsorbable Biostar occluder.
    Zeybek C; Kırbaş A; Yalçın Y; Bilal MS
    Turk Kardiyol Dern Ars; 2012 Oct; 40(7):623-7. PubMed ID: 23363948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracardiac Fontan fenestration using the SafeSept transseptal guidewire and snare-controlled diabolo-shaped covered-stent placement.
    Casadonte JR; Wax DF; Gossett JG
    Catheter Cardiovasc Interv; 2016 Feb; 87(3):426-31. PubMed ID: 26105575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of transcatheter closure of extracardiac Fontan fenestration by Amplatzer duct or septal occluder in three patients].
    Li SG; Jiang SL; Xu ZY; Huang LJ; Zhao SH; Jin JL; Yu JH; Xu JP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):489-92. PubMed ID: 19100057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events.
    El-Said H; Hegde S; Foerster S; Hellenbrand W; Kreutzer J; Trucco SM; Holzer R; Burch G; Mirani A; Nicolas R; Porras D; Bergersen L; Moore J
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):227-33. PubMed ID: 25257700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creation of a defined and stable Fontan fenestration with the new Occlutech Atrial Flow Regulator (AFR®).
    Lehner A; Schulze-Neick I; Haas NA
    Cardiol Young; 2018 Aug; 28(8):1062-1066. PubMed ID: 29972113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracardiac Fontan operation without cardiopulmonary bypass.
    Tireli E; Ugurlucan M; Basaran M; Kafali E; Harmandar B; Sayin OA; Sungur Z; Dayioglu E
    J Cardiovasc Surg (Torino); 2006 Dec; 47(6):699-704. PubMed ID: 17043618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Explantation of patent foramen ovale closure devices: a multicenter survey.
    Verma SK; Tobis JM
    JACC Cardiovasc Interv; 2011 May; 4(5):579-85. PubMed ID: 21596333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous valvulation of failing Fontan: rationale, acute effects and follow-up.
    Malekzadeh-Milani S; Ladouceur M; Iserin L; Boudjemline Y
    Arch Cardiovasc Dis; 2014 Nov; 107(11):599-606. PubMed ID: 25282330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrid perventricular device closure of doubly committed subarterial ventricular septal defects: mid-term results.
    Lin K; Zhu D; Tao K; Gan C; Tang H; Feng Y; An Q
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E225-32. PubMed ID: 23413226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual shunting after percutaneous PFO closure: how to manage and how to close.
    Butera G; Sarabia JF; Saracino A; Chessa M; Piazza L; Carminati M
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):950-8. PubMed ID: 23804551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter closure of fenestration with detachable coils after the Fontan operation.
    Kim SH; Kang IS; Huh J; Lee HJ; Yang JH; Jun TG
    J Korean Med Sci; 2006 Oct; 21(5):859-64. PubMed ID: 17043420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fontan fenestration closure in the catheterization laboratory--echocardiographic evaluation of residual right to left shunts.
    Gomez C; Lloyd T; Mosca R; Bove E; Ludomirsky A
    Am J Cardiol; 1998 Nov; 82(10):1304-6, A10-1. PubMed ID: 9832117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.